Biomarin Pharmaceutical Inc Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income 5.20M177.16M-117.48M-169.69M-185.26M-159.59M-248.63M-630.21M-117.04M-77.21M-23.85M854.03M-64.08M141.56M167.65M426.86M
Depreciation and Depletion 15.90M23.30M31.90M34.90M36.50M44.30M50.10M73.20M75.80M90.38M51.80M43.00M46.10M38.60M40.30M46.60M
Share-based Compensation 36.01M38.36M43.91M47.97M64.38M86.41M111.53M134.64M140.26M148.82M159.87M189.71M197.26M196.31M207.10M201.57M
Deferred Taxes -230.58M4.36M-9.92M-8.90M-25.62M-76.83M-228.05M44.46M-68.38M-82.76M-889.99M-15.61M-52.09M-44.98M56.10M
Gains from Equity Investments 2.59M2.99M
Gains from Sales and Divestitures 0.16M0.21M0.30M0.38M0.49M0.75M0.84M
Gains from Investment Securities 4.60M14.90M16.32M13.87M13.16M11.48M10.32M8.86M8.11M50.00M42.68M52.82M45.80M54.28M76.32M77.56M
Asset Writedowns and Impairment 5.85M6.71M0.94M211.50M599.12M75.61M38.61M19.89M
Non-cash Items 8.88M9.90M8.72M8.39M8.09M630.95M304.36M281.14M
Cash from Operations 122.38M18.75M18.41M17.61M-57.34M-70.42M-219.50M-227.84M-8.76M20.21M48.26M85.36M304.54M175.90M159.26M572.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -1.44M-4.45M-4.04M-4.47M-5.90M-7.21M-2.18M-1.30M-3.08M-0.36M2.00M-0.57M-5.16M-3.04M9.23M8.35M
Amortization of Deferred Charges 2.58M1.05M0.96M5.88M27.23M28.49M29.93M32.30M31.19M13.96M16.51M4.15M4.12M4.19M3.36M
Depreciation & Amortization (CF) 29.26M27.74M35.05M44.34M36.01M45.87M47.19M96.91M87.86M95.67M105.30M105.17M108.04M101.97M104.39M96.43M
Change in Working Capital
Change in Receivables 19.24M13.04M18.46M4.23M8.74M25.95M16.37M51.48M25.26M54.27M37.85M59.03M-65.57M82.03M190.44M57.91M
Change in Inventory 5.50M31.04M20.42M-1.42M21.10M22.34M50.99M64.51M96.89M23.75M107.55M61.15M35.06M68.26M157.06M63.53M
Change in Accured Expenses 7.80M2.17M9.77M37.41M20.30M38.04M90.30M-53.20M45.52M38.39M77.09M-87.03M15.69M59.02M68.85M-32.24M
Other Working Capital Changes 1.29M-3.24M-2.54M3.51M12.07M2.21M-25.80M-19.32M20.69M17.77M27.01M-18.31M-29.76M-7.82M50.34M3.78M
Investing Activities
Capital Expenditures 89.80M49.46M73.22M44.57M65.19M117.06M227.65M148.38M199.22M144.62M145.03M114.31M95.58M120.96M96.69M85.42M
Sales of Property, Plant and Equipment 50.00M25.00M67.16M103.33M10.00M
Change in Intangibles 81.00M67.50M410.00M125.00M18.38M23.21M23.65M10.58M10.92M11.99M
Acquisitions 17.52M32.95M9.88M538.39M2.79M
Change in Acquisitions & Divestments 663.04M206.36M281.99M237.84M288.64M808.31M424.71M367.57M425.96M993.73M740.21M555.83M691.05M620.00M864.86M633.02M
Cash from Investing Activities -111.14M-101.34M-89.56M-195.65M-298.85M196.33M-1179.60M-484.05M-305.46M264.35M-31.03M-53.62M-366.31M-20.03M-111.24M136.49M
Financing Activities
Other financing activities 0.11M0.54M-1.97M-2.67M-0.82M-2.27M-3.92M-0.59M-0.40M-2.60M-2.29M-3.18M
Cash from Financing Activities -88.98M3.50M29.34M312.29M746.67M184.20M925.72M727.11M507.14M-388.01M-74.67M181.12M-0.05M-18.65M-18.73M-526.45M
Additional items
Exchange Rate Effect -2.23M-3.40M-5.07M-3.93M-3.23M-0.60M0.90M-1.15M-0.06M0.03M1.31M4.83M
Change in Cash -77.74M-79.09M-41.81M134.25M388.25M306.70M-478.45M11.29M189.70M-104.05M-56.54M211.71M-61.88M137.25M30.60M187.72M
Free Cash Flow 32.58M-30.71M-54.80M-26.96M-122.53M-187.48M-447.15M-376.22M-207.98M-124.41M-96.76M-28.95M208.96M54.94M62.57M487.42M
Net Cash Flow -77.74M-79.09M-41.81M134.25M390.48M310.10M-473.37M15.22M192.93M-103.45M-57.44M212.86M-61.83M137.22M29.29M182.88M